VA

Venkata Anupama Alamanda

Active Director Director DIN 09202734
DIN 09202734 First appointment Jun 2021 Primary industry Chemicals and Materials
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Venkata Anupama Alamanda

Data last updated:

Venkata Anupama Alamanda is a Director at Drugelis Pharma Private Limited (since 2021). The company operates in Chemicals and Materials.

DIN 09202734
Primary Designation Director
Industry Chemicals and Materials
First Appointment 14 Jun 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Drugelis Pharma Private Limited U24110AP2021PTC118519
Director14 Jun 20212021Active

Board colleagues of Venkata Anupama Alamanda

NameDINCompanyDesignation
Shanthi Swaroopini Alamanda09202735Drugelis Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Drugelis Pharma Private Limited
Premium access

Shareholding and investment profile for Venkata Anupama Alamanda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkata Anupama Alamanda

Venkata Anupama Alamanda currently holds 1 directorship: Drugelis Pharma Private Limited (Director, since 14 Jun 2021).

Venkata Anupama Alamanda was first appointed on 14 Jun 2021 as Director at Drugelis Pharma Private Limited.

The current boards of Venkata Anupama Alamanda's companies include Shanthi Swaroopini Alamanda (Drugelis Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available